SHARE CAPITAL | 11. SHARE CAPITAL The Company’s authorized share capital consists of an unlimited number of common shares. SCHEDULE OF AUTHORIZED SHARE CAPITAL Number of shares (000’s) $ Year ended December 31, 2020 Opening balance 22,491 114,840 Shares issued on exercise of stock options 261 602 Shares issued on exercise of RSUs and DSUs 382 1,627 Shares issued on exercise of warrants 2 8 Shares issued on acquisition of Otis Gold Corp (1) 8,131 16,370 Shares issued as part of Credit Facility (2) 107 180 Shares issued to settle payables (3) 671 1,738 Value of shares issued in asset acquisition (4) 66 246 Shares issued to settle interest on convertible debentures (5) 228 588 Balance at December 31, 2020 32,339 136,199 Period ended September 30, 2021 Opening balance 32,339 136,199 Shares issued on exercise of stock options 15 55 Shares issued on exercise of RSUs and DSUs 183 678 Value of shares issued in asset acquisition (4) 232 336 Shares issued to settle interest on convertible debentures (5) 286 727 Balance at September 30, 2021 33,055 137,995 (1) On April 22, 2020, the Company completed the acquisition of Otis. Otis shareholders received 0.046 8,130,630 2.85 (2) On March 16, 2020, the Company closed a $ 6,000 bridge-loan credit facility (the “Credit Facility”) with Sprott Private Resource Lending II (Collector), LP (“Sprott Lending”). The Credit Facility bore interest of 10% per annum, compounded and payable monthly, and was due and payable in full on or before September 14, 2020. In consideration for the Credit Facility, Excellon issued 107,291 common shares to Sprott Lending. The Company repaid the Credit Facility on August 4, 2020 on the closing of the Financing (Note 10). (3) During the second and third quarters of 2020, the Company issued 670,974 2,098 196 261 (4) On September 21, 2020 and in accordance with the Globex Agreement, the second issuance of 65,657 325 100 232,240 425 100 (5) The Company elected to pay the December 31, 2020 and June 30, 2021 interest payments on the Debentures (Note 10) in common shares valued at C$ 754 ($ 588 ) and C$ 888 ($ 727 ) respectively. Excellon Resources Inc. Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (in thousands of U.S. dollars, except share and per share data) The outstanding number and weighted average exercise prices of equity-settled Stock Options, Warrants, Deferred Share Units (“DSUs”) and Restricted Share Units (“RSUs”) are as follows: SCHEDULE OF OUTSTANDING NUMBER AND WEIGHTED AVERAGE EXERCISE PRICES Options Warrants Options Outstanding Weighted Average Exercise Price (CAD) Warrants Outstanding (2) Weighted Average Exercise Price (CAD) RSUs Outstanding DSUs Outstanding Outstanding at January 1, 2020 461,000 5.59 1,092,500 7.00 572,485 467,572 Granted/issued/acquired (1) 1,002,395 3.34 1,448,488 5.23 337,331 217,264 Exercised/settled (260,596 ) 1.93 (2,400 ) 3.45 (224,750 ) (193,507 ) Expired (332,359 ) 5.20 - - (91,332 ) - Forfeited (23,004 ) 4.26 - - (128,223 ) - Outstanding at December 31, 2020 847,437 4.21 2,538,588 6.00 465,511 491,330 Exercisable at December 31, 2020 548,009 4.52 2,538,588 6.00 - 98,417 Outstanding at January 1, 2021 847,437 4.21 2,538,588 6.00 465,511 491,330 Granted/issued 212,500 4.14 - - 428,562 199,353 Exercised/settled (15,000 ) 3.05 - - (41,117 ) (146,068 ) Expired (59,450 ) 4.75 (1,092,400 ) 7.00 - - Forfeited (27,584 ) 3.72 - - (29,000 ) - Outstanding at September 30, 2021 957,903 4.20 1,446,188 5.24 823,956 544,615 Exercisable at September 30, 2021 757,944 4.32 1,446,188 5.24 - 98,417 (1) On April 22, 2020, the Company issued 531,895 305,060 130,365 July 22, 2020 (2) The Company has the following warrants outstanding: ● 302,760 3.30 March 29, 2022 ● 1,143,428 warrants with an exercise price of C$ 5.75 , expiring on July 30, 2023 (Note 10). On August 27, 2021, 1,092,400 7.00 Excellon Resources Inc. Notes to the Condensed Consolidated Financial Statements For the three and nine months ended September 30, 2021 and 2020 (in thousands of U.S. dollars, except share and per share data) Options outstanding and exercisable are as follows: SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE Exercise Price Range (CAD) Stock Options Outstanding Weighted Average Remaining Contractual Life (years) Stock Options Exercisable Weighted Average $ 2.00 3.99 426,787 1.89 333,912 2.99 $ 4.00 5.99 440,116 2.61 333,032 4.54 $ 6.00 7.99 15,000 0.66 15,000 7.63 $ 8.00 9.99 76,000 0.93 76,000 8.51 957,903 2.12 757,944 4.32 Compensation expense is recognized over the vesting period of the grant with the corresponding equity impact recorded in contributed surplus. Share-based compensation expense comprises the following: SCHEDULE OF SHARE BASED COMPENSATION EXPENSE Three months ended Nine months ended September 30 September 30 September 30 September 30 2021 2020 2021 2020 $ $ $ $ Stock options 82 127 427 367 RSU 152 110 439 691 DSU 52 59 548 524 286 296 1,414 1,582 |